Article
Neurological improvement following intravenous high-dose folinic acid for cerebral folate transporter deficiency caused by FOLR-1 mutation.
European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society - 1 Sept 2016
Delmelle Françoise, Thöny Beat, Clapuyt Philippe, Blau Nenad, Nassogne Marie-Cécile
Abstract excerpt
BACKGROUND: Cerebral folate transporter deficiency caused by FOLR-1 mutations has been described in 2009. This condition is characterized by a 5MTHF level <5 nmol/l in the CSF, along with regression of acquisition in the second year of life, ataxia, and refractory myoclonic epilepsy. Oral or intravenous folinic acid (5-formyltetrahydrofolate) treatment has been shown to improve clinical status. CASE PRESENTATION:...
Topics
- Child
- Child, Preschool
- Female
- Folate Receptor 1
- Humans
- Infusions, Intravenous
- Leucovorin
- Mutation
- Neuroaxonal Dystrophies
- Siblings
